Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
87.31
0.00 (0.00%)
Dec 31, 2025, 4:00 PM EST - Market closed
Globus Medical Revenue
Globus Medical had revenue of $769.05M in the quarter ending September 30, 2025, with 22.91% growth. This brings the company's revenue in the last twelve months to $2.77B, up 11.75% year-over-year. In the year 2024, Globus Medical had annual revenue of $2.52B with 60.62% growth.
Revenue (ttm)
$2.77B
Revenue Growth
+11.75%
P/S Ratio
4.28
Revenue / Employee
$522,605
Employees
5,300
Market Cap
11.69B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.52B | 950.88M | 60.62% |
| Dec 31, 2023 | 1.57B | 545.63M | 53.34% |
| Dec 31, 2022 | 1.02B | 64.74M | 6.76% |
| Dec 31, 2021 | 958.10M | 169.06M | 21.43% |
| Dec 31, 2020 | 789.04M | 3.67M | 0.47% |
| Dec 31, 2019 | 785.37M | 72.40M | 10.15% |
| Dec 31, 2018 | 712.97M | 76.99M | 12.11% |
| Dec 31, 2017 | 635.98M | 71.98M | 12.76% |
| Dec 31, 2016 | 563.99M | 19.24M | 3.53% |
| Dec 31, 2015 | 544.75M | 70.38M | 14.84% |
| Dec 31, 2014 | 474.37M | 39.91M | 9.19% |
| Dec 31, 2013 | 434.46M | 48.47M | 12.56% |
| Dec 31, 2012 | 385.99M | 54.52M | 16.45% |
| Dec 31, 2011 | 331.48M | 43.28M | 15.02% |
| Dec 31, 2010 | 288.20M | 33.85M | 13.31% |
| Dec 31, 2009 | 254.34M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
GMED News
- 7 weeks ago - Globus Medical: Straightening Its Back - Seeking Alpha
- 7 weeks ago - Globus Medical Stock Soars After Earnings. Where It's Seeing the Strength. - Barrons
- 2 months ago - Globus Medical, Inc. (GMED) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Globus Medical Reports Third Quarter 2025 Results - GlobeNewsWire
- 2 months ago - Is Wall Street Underestimating Globus Medical Stock's Potential? - Forbes
- 2 months ago - Globus Medical Schedules Third Quarter Earnings Release and Conference Call - GlobeNewsWire
- 2 months ago - Globus Medical Launches ANTHEM™ Elbow Fracture System: A Comprehensive Plating Portfolio for Complex Elbow Trauma - GlobeNewsWire
- 4 months ago - Globus Medical, Inc. Secures Jury Verdict in Delaware Patent Litigation Against Life Spine, Inc. - GlobeNewsWire